July 2014

Patentable parthenotes? Advocate General says yes
In the latest development to the patentability of human stem cells, the AG has recommended that stem cells derived from parthenogenically activated oocytes should not be excluded from patentability any longer. The AG drew the distinction between totipotent and pluripotent cells, noting that cells that do not have the capacity to develop into a human being should not be excluded from patentability.
Read More
31
Jul
2014
UK High Court makes sense of CJEU’s decision on interpretation of Article 3(a)
In a pro-patentee judgment, the UK High Court suggests that SPCs can be based on most types of claim provided that the product which is the subject of the SPC falls within the scope of the claim.
Read More
29
Jul
2014
Intellectual property rights and 3D printing: a threat or an opportunity?
The latest developments in 3D printing and the implications for IP protection.
Read More
28
Jul
2014
Should High stay, for EPO? Actavis and Pharmacia clash in the High Court
Mr Justice Arnold in the Patents Court of the High Court of England and Wales (the ‘Patents Court’) initially refused a request by the patentee, Pharmacia, for a stay of UK revocation proceedings brought by Actavis, pending the outcome of opposition proceedings at the EPO based on three undertakings.
Read More
24
Jul
2014
Changes to searches on applications entering Europe via the PCT
As of 1st November 2014, the EPO is changing the way it searches PCT applications entering the European regional phase which are considered to relate to more than one invention. These changes will result in increased flexibility for the applicant and should help to reduce the likelihood of encountering unexpected costs.
Read More
14
Jul
2014

Type

Service

Sector

Archive